$QUBT
Quantum Computing Inc. Stock $qubt

$qubt Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000121390024028799 Filed on April 01, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$27.33K	$74.89K	$358.1K
YoY Change	-77.33%	5750.78%	163.96%
Cost Of Revenue	$15.92K	$64.52K	$195.6K
YoY Change	-71.69%	235.34%	221.07%
Gross Profit	$11.41K	$10.37K	$162.4K
YoY Change	-82.25%	-157.74%	117.38%
Gross Profit Margin	41.75%	13.85%	45.36%
Selling, General & Admin	$5.035M	$6.288M	$20.94M
YoY Change	88.58%	-62.55%	139.93%
% of Gross Profit	44124.19%	60631.92%	12890.82%
Research & Development	$1.409M	$1.630M	$6.448M
YoY Change	-8.16%	14.77%	41.34%
% of Gross Profit	12351.53%	15718.42%	3970.01%
Depreciation & Amortization	$895.6K	$1.778M	$1.958M
YoY Change	-42.0%	16.2%	-40.69%
% of Gross Profit	7849.52%	17143.39%	1205.45%
Operating Expenses	$6.444M	$7.918M	$27.38M
YoY Change	-17.93%	-56.52%	-25.29%
Operating Profit	-$6.432M	-$7.907M	-$27.22M
YoY Change	-17.4%	-56.62%	-25.58%
Interest Expense	-$473.9K	-$183.9K	-$1.648M
YoY Change	-5.77%	-45.64%	46.5%
% of Operating Profit
Other Income/Expense, Net	$0.00	-$215.1K	-$861.1K
YoY Change	-100.0%	-2.15%	-57.25%
Pretax Income	-$6.906M	-$8.306M	-$29.73M
YoY Change	-18.81%	-55.79%	-22.96%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$6.906M	-$8.306M	-$29.73M
YoY Change	-18.81%	-55.79%	-22.96%
Net Earnings / Revenue	-25270.33%	-11091.16%	-8303.5%
Basic Earnings Per Share	-$0.08		-$0.38
Diluted Earnings Per Share	-$0.08	-$0.10	-$0.38
COMMON SHARES
Basic Shares Outstanding	91.36M shares	75.10M shares	77.45M shares
Diluted Shares Outstanding	81.93M shares		95.90M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.101M	$2.059M	$2.059M
YoY Change	-9.82%	-61.21%	-61.21%
Cash & Equivalents	$6.101M	$2.059M	$2.059M
Short-Term Investments
Other Short-Term Assets	$498.5K	$427.6K	$427.6K
YoY Change	1076.04%	915.51%	-74.16%
Inventory	$155.3K	$72.65K	$72.65K
Prepaid Expenses		$138.5K
Receivables	$603.7K	$622.2K	$622.2K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$7.358M	$3.182M	$3.182M
YoY Change	3.72%	-43.06%	-54.39%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.116M	$3.670M	$3.670M
YoY Change	290.84%	276.3%	276.3%
Goodwill	$55.60M	$60.36M
YoY Change	-5.96%	2.09%
Intangibles		$11.39M
YoY Change		-48.76%
Long-Term Investments
YoY Change
Other Assets	$129.1K	$129.1K	$129.1K
YoY Change	-99.84%	-99.84%
Total Long-Term Assets	$75.71M	$75.55M	$75.55M
YoY Change	-8.16%	-9.75%	-8.23%
TOTAL ASSETS
Total Short-Term Assets	$7.358M	$3.182M	$3.182M
Total Long-Term Assets	$75.71M	$75.55M	$75.55M
Total Assets	$83.06M	$78.73M	$78.73M
YoY Change	-7.22%	-11.84%	-11.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.681M	$1.462M	$1.462M
YoY Change	82.32%	67.63%	67.63%
Accrued Expenses	$549.5K	$195.9K	$195.9K
YoY Change	-68.03%	-94.5%	-96.02%
Deferred Revenue	$8.000K
YoY Change
Short-Term Debt	$535.7K	$2.496M	$2.496M
YoY Change	-93.54%	366.04%	366.04%
Long-Term Debt Due		$2.496M	$1.925M
YoY Change		366.04%
Total Short-Term Liabilities	$3.026M	$4.620M	$4.620M
YoY Change	-75.93%	-29.42%	-29.42%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Other Long-Term Liabilities	$775.1K	$840.1K	$840.1K
YoY Change	9889.69%	272.91%	272.91%
Total Long-Term Liabilities	$775.1K	$840.1K	$840.1K
YoY Change	6428.26%	-89.31%	-89.31%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.026M	$4.620M	$4.620M
Total Long-Term Liabilities	$775.1K	$840.1K	$840.1K
Total Liabilities	$3.801M	$5.460M	$5.460M
YoY Change	-69.8%	-62.09%	-62.09%
SHAREHOLDERS EQUITY
Retained Earnings	-$138.4M	-$149.7M
YoY Change	7.71%	24.78%
Common Stock	$9.000K	$7.745K
YoY Change	48.78%	38.4%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$79.26M	$73.27M	$73.27M
YoY Change
Total Liabilities & Shareholders Equity	$83.06M	$78.73M	$78.73M
YoY Change	-7.22%	-11.84%	-11.84%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$6.906M	-$8.306M	-$29.73M
YoY Change	-18.81%	-55.79%	-22.96%
Depreciation, Depletion And Amortization	$895.6K	$1.778M	$1.958M
YoY Change	-42.0%	16.2%	-40.69%
Cash From Operating Activities	-$4.442M	-$5.301M	-$19.94M
YoY Change	-5.82%	-11.54%	13.57%
INVESTING ACTIVITIES
Capital Expenditures	$1.579M	-$42.01K	$2.118M
YoY Change	316.79%	-99.93%	143.53%
Acquisitions
YoY Change
Other Investing Activities		$70.00K	-$500.0K
YoY Change		-99.73%	-63.17%
Cash From Investing Activities	-$1.579M	$112.0K	-$2.618M
YoY Change	316.79%	-99.87%	17.54%
FINANCING ACTIVITIES
Cash Dividend Paid	$215.0K
YoY Change	-2.27%
Common Stock Issuance & Retirement, Net			$25.50M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	10.06M	-130.7K	19.31M
YoY Change	53.58%	-99.84%	131.13%
NET CHANGE
Cash From Operating Activities	-4.442M	-5.301M	-19.94M
Cash From Investing Activities	-1.579M	112.0K	-2.618M
Cash From Financing Activities	10.06M	-130.7K	19.31M
Net Change In Cash	4.041M	-5.319M	-3.249M
YoY Change	177.5%	4.85%	-71.57%
FREE CASH FLOW
Cash From Operating Activities	-$4.442M	-$5.301M	-$19.94M
Capital Expenditures	$1.579M	-$42.01K	$2.118M
Free Cash Flow	-$6.021M	-$5.259M	-$22.06M
YoY Change	18.16%	-110.01%	19.71%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	129045	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	60271	usd
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-40615
CY2023	dei	Entity Registrant Name EntityRegistrantName	QUANTUM COMPUTING INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-4533053
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	5 Marine View Plaza
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 214
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Hoboken
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2023	dei	City Area Code CityAreaCode	(703)
CY2023	dei	Local Phone Number LocalPhoneNumber	436-2121
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	46073808	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	91357640	shares
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Name AuditorName	BF Borgers CPA PC
CY2023	dei	Auditor Firm AuditorFirmId	5041
CY2023	dei	Auditor Location AuditorLocation	Lakewood, CO
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2059285	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5308466	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	65000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	12774	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	138460	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	224302	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	557236	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	289117	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	182994	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	72650	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	3181748	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	5728536	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2869658	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	975169	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	799942	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1186857	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	11388015	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	22223725	usd
CY2023Q4	us-gaap	Goodwill Goodwill	60359867	usd
CY2022Q4	us-gaap	Goodwill Goodwill	59125773	usd
CY2023Q4	us-gaap	Assets Assets	78728275	usd
CY2022Q4	us-gaap	Assets Assets	89300331	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1461541	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	871887	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	195923	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3559981	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	458	usd
CY2023Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	215119	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	219844	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2496480	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	535684	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	250116	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	131849	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4619637	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5319245	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7858280	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	840085	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1226075	usd
CY2023Q4	us-gaap	Liabilities Liabilities	5459722	usd
CY2022Q4	us-gaap	Liabilities Liabilities	14403600	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	149	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	150	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	77451356	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	77451356	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	55963334	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	55963334	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	7745	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	5596	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	167944651	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	151163909	usd
CY2023Q4	qubt	Apic Beneficial Conversion Feature In Equity APICBeneficialConversionFeatureInEquity	4898835	usd
CY2022Q4	qubt	Apic Beneficial Conversion Feature In Equity APICBeneficialConversionFeatureInEquity	4898835	usd
CY2023Q4	qubt	Apic Stock Based Compensation APICStockBasedCompensation	50135626	usd
CY2022Q4	qubt	Apic Stock Based Compensation APICStockBasedCompensation	38816022	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-149718453	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-119987781	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	73268553	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	74896731	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	78728275	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	89300331	usd
CY2023	us-gaap	Revenues Revenues	358047	usd
CY2022	us-gaap	Revenues Revenues	135648	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	195640	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	60934	usd
CY2023	us-gaap	Gross Profit GrossProfit	162407	usd
CY2022	us-gaap	Gross Profit GrossProfit	74714	usd
CY2023	us-gaap	Labor And Related Expense LaborAndRelatedExpense	4047910	usd
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	4326733	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	838592	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	1278170	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6447703	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4561794	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	8722766	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	17761467	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7326713	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8725892	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	27383684	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	36654056	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-27221277	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-36579342	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	295478	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	46891	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	602059	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	225282	usd
CY2023	qubt	Interest Expense Preferred Dividends InterestExpensePreferredDividends	861071	usd
CY2022	qubt	Interest Expense Preferred Dividends InterestExpensePreferredDividends	889219	usd
CY2023	us-gaap	Financing Interest Expense FinancingInterestExpense	1341743	usd
CY2022	us-gaap	Financing Interest Expense FinancingInterestExpense	946748	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2509395	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2014358	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-29730672	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-38593700	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77451356	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55963334	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95896430	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74340487	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.69
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.31
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.52
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16201898	usd
CY2022	us-gaap	Stock Granted During Period Value Sharebased Compensation Forfeited StockGrantedDuringPeriodValueSharebasedCompensationForfeited	1	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	319950	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	68724976	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	14358891	usd
CY2022	qubt	Adjustmentsto Additional Paidin Capital Preferred Oid Amortization AdjustmentstoAdditionalPaidinCapitalPreferredOIDAmortization	318750	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	13518567	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	47400	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-38593700	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	74896731	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	74896731	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25496364	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	2413500	usd
CY2023	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	596	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	8347126	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	7299278	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	1239882	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-29730672	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	73268553	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-29730672	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-38593700	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1957768	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3433674	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	-4448	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	8722766	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	17761467	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	52227	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	12774	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	70484	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	77515	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-91813	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-318141	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	1128166	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	582854	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	218574	usd
CY2023	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	458	usd
CY2023	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-984786	usd
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-462362	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-611272	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	1451357	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19940521	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-17240117	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2117990	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	869687	usd
CY2023	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	500000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1356071	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2617990	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2225758	usd
CY2023	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-6187034	usd
CY2022	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	8035684	usd
CY2023	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	25496364	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19309330	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8035684	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-3249181	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-11430191	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5308466	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16738657	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2059285	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5308466	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	812966	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	83083867	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 1 – <span style="text-decoration:underline">Nature of the Organization and Business</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Corporate History</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quantum Computing Inc. (“QCi” or the “Company”) was formed in the State of Nevada on July 25, 2001, under its prior name, Ticketcart, Inc. The Company redomiciled to Delaware on February 22, 2018 and changed its name to Quantum Computing Inc. Effective July 20, 2018, the trading symbol for the Company’s common stock, par value $0.0001, on the OTC Market changed from “IBGH” to “QUBT”. On July 15, 2021 the Company uplisted to The Nasdaq Stock Market. On June 16, 2022, the Company merged with QPhoton, Inc. (“QPhoton”), a developer of quantum photonic systems and related technologies and applications.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Nature of Business</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QCi is an American company utilizing integrated photonics and non-linear quantum optics to deliver quantum systems for high-performance computing applications. Quantum’s products are designed to operate at room temperature and low power. Our core technology enables the execution of a go-to-market strategy which emphasizes accessibility and affordability. Our quantum systems enable subject matter experts (SMEs) and end users to deliver critical business solutions today.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company initially focused on providing software tools and applications for several commercially available quantum computers. However, following the June 2022 merger with QPhoton and its associated intellectual property and engineering team, the Company now offers integrated high-performance quantum systems and services.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The core of our quantum information services today is our Entropy Quantum Computing (“EQC”) technology. We have built room-temperature, photonic quantum information processing systems underpinned by a series of patented and patent pending technologies. Our technology, supported by professional services through our “Quantum Solutions” offering, helps our clients benefit from the technology today. In addition, our leading-edge photonic technology and engineering teams will enable QCi to continue to enhance quantum LIDAR and sensing systems, imaging systems, quantum-secured network solutions, and photonic quantum chips.</span></p>
CY2023	us-gaap	Revenues Revenues	358047	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-29730672	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19940521	usd
CY2023Q4	qubt	Working Capital Deficit WorkingCapitalDeficit	1437889	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-149718453	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Use of Estimates:</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These financial statements have been prepared in accordance with accounting principles generally accepted in the United States which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Some of the more significant estimates required to be made by management include the determination of reserves for accounts receivable, stockholders’ equity-based transactions and liquidity assessment. Actual results may differ from these estimates.</p>
CY2023Q4	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P12M
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	7028337	shares
CY2023	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	83083868	usd
CY2023	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	81939939	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	16109	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Financial Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets	116315	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Marketable Securities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities	97768	usd
CY2023Q4	qubt	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncompete Agreement With Founder BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncompeteAgreementWithFounder	2722000	usd
CY2023Q4	qubt	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Website Domain Trade Name And Trademark BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWebsiteDomainTradeNameAndTrademark	969000	usd
CY2023Q4	qubt	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Technology And Licensed Patents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTechnologyAndLicensedPatents	12200000	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	2888246	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	68706993	usd
CY2023	qubt	Net Loss Before Adjustment NetLossBeforeAdjustment	31320173	usd
CY2023	us-gaap	Income Tax Effects Allocated Directly To Equity Prior Period Adjustment IncomeTaxEffectsAllocatedDirectlyToEquityPriorPeriodAdjustment	68700000	usd
CY2022Q2	us-gaap	Investment Sold Not Yet Purchased Balance Principal Amount InvestmentSoldNotYetPurchasedBalancePrincipalAmount	1250000	usd
CY2022Q2	us-gaap	Loans Assumed1 LoansAssumed1	2500000	usd
CY2022Q1	us-gaap	Investment Interest Rate InvestmentInterestRate	0.06	pure
CY2022Q2	us-gaap	Investment Interest Rate InvestmentInterestRate	0.15	pure
CY2023Q1	qubt	Extension Year ExtensionYear	P1Y
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4502985	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3248495	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11388015	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	22223725	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3248495	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2843991	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2352518	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1936657	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1831682	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1742857	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	680310	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11388015	usd
CY2023Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	59125773.38	usd
CY2022Q4	us-gaap	Goodwill Goodwill	59125773	usd
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	9581220	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	59125773	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	8347126	usd
CY2023Q4	us-gaap	Goodwill Goodwill	60359867	usd
CY2022Q4	us-gaap	Goodwill Goodwill	59125773	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	14528229	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	9703519	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	14528229	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9703519	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	14528229	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3141939	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1045718	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	272281	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	70549	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2869658	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	975169	usd
CY2023	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	2096221	usd
CY2023Q4	qubt	Property Plant And Equipment Collections Capitalized PropertyPlantAndEquipmentCollectionsCapitalized	2500	usd
CY2021Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	200592	usd
CY2021Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	150000	usd
CY2021Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	150000	usd
CY2021Q1	us-gaap	Notes Payable NotesPayable	500592	usd
CY2021Q1	us-gaap	Notes Payable NotesPayable	500592	usd
CY2021Q3	us-gaap	Notes Payable NotesPayable	500592	usd
CY2023	us-gaap	Proceeds From Sales Of Business Affiliate And Productive Assets ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets	375000	usd
CY2022Q3	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	750000	usd
CY2022Q3	qubt	Outstanding Balance OutstandingBalance	1.20	pure
CY2023	qubt	Redemption Amount RedemptionAmount	750000	usd
CY2023	qubt	Outstanding Balance Amount OutstandingBalanceAmount	7000000	usd
CY2023Q4	us-gaap	Derivative Variable Interest Rate DerivativeVariableInterestRate	0.15	pure
CY2023Q2	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	2000000	usd
CY2023Q2	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	500000	usd
CY2023Q4	us-gaap	Percentage Of Debt Hedged By Interest Rate Derivatives PercentageOfDebtHedgedByInterestRateDerivatives	0.10	pure
CY2023Q4	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	5.5
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	7
CY2023Q2	us-gaap	Common Stock Shares Held In Employee Trust Shares CommonStockSharesHeldInEmployeeTrustShares	853600	shares
CY2023Q4	us-gaap	Common Stock Shares Held In Employee Trust Shares CommonStockSharesHeldInEmployeeTrustShares	23600	shares
CY2023Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	75000	shares
CY2022Q3	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	16000000	shares
CY2023Q1	us-gaap	Shares Issued SharesIssued	1000000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9601237	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.42
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	5340000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.38
CY2023	qubt	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm1	P5Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1097738	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.32
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13843499	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.02
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y8M12D
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	7978074	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	3.39
CY2023	qubt	Sharebased Compensation Arrangement By Sharebased Payment Award Options Contractual Term Vested SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsContractualTermVested	P3Y3M18D
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	13843499	shares
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	7978074	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.38
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.38
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8722766	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17761467	usd
CY2023	qubt	Common Stock Options CommonStockOptions	6000000	usd
CY2023	qubt	Expected To Be Recognized Over A Period ExpectedToBeRecognizedOverAPeriod	P4Y
CY2020Q3	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	171000	shares
CY2020Q3	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	2
CY2021Q4	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	1545459	shares
CY2021Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	7
CY2022Q2	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	6325503	shares
CY2022Q2	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.0001
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	338319	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	576078	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	591551	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	515981	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	191008	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	638740	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1619197	usd
CY2023	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	411700	usd
CY2022	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	125238	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y8M12D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y8M12D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2023	qubt	Consideration Agreement Description ConsiderationAgreementDescription	As consideration for the license and other rights granted under the agreement, QPhoton agreed to pay the following: (i) $35,000 within 30 days of execution of the agreement, (ii) $28,000 within 30 days of each annual anniversary of the effective date, (iii) equity in the Company equivalent to nine percent of the membership units of the Company within 30 days of the execution of the agreement, and (iv) royalties of 3.5% of the Net Sales Price of each licensed product sold or licensed by the Company during the quarter then-ended, for which it also received payment, concurrent with the delivery of the relevant quarterly report.
CY2023	us-gaap	Salaries And Wages SalariesAndWages	400000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent		usd
CY2022Q4	us-gaap	Inventory Net InventoryNet		usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent		usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2022	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums		usd
CY2022	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable		usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
CY2023	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock		usd
CY2023	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
CY2022	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023	us-gaap	Stock Issued1 StockIssued1		usd
CY2021Q4	us-gaap	Goodwill Goodwill		usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1254490	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q2	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	53568.44	usd
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023	qubt	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercised Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm1
CY2023	qubt	Sharebased Compensation Arrangement By Sharebased Payment Award Options Forfeited Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm1
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001758009

Files In Submission

Name	View Source	Status
0001213900-24-028799-index-headers.html	Edgar Link	pending
0001213900-24-028799-index.html	Edgar Link	pending
0001213900-24-028799.txt	Edgar Link	pending
0001213900-24-028799-xbrl.zip	Edgar Link	pending
ea0202448-10k_quantum.htm	Edgar Link	pending
ea020244801ex10-26_quantum.htm	Edgar Link	pending
ea020244801ex10-27_quantum.htm	Edgar Link	pending
ea020244801ex10-28_quantum.htm	Edgar Link	pending
ea020244801ex10-31_quantum.htm	Edgar Link	pending
ea020244801ex10-32_quantum.htm	Edgar Link	pending
ea020244801ex21-1_quantum.htm	Edgar Link	pending
ea020244801ex23-1_quantum.htm	Edgar Link	pending
ea020244801ex31-1_quantum.htm	Edgar Link	pending
ea020244801ex31-2_quantum.htm	Edgar Link	pending
ea020244801ex32-1_quantum.htm	Edgar Link	pending
ea020244801ex32-2_quantum.htm	Edgar Link	pending
ea020244801ex4-4_quantum.htm	Edgar Link	pending
ea020244801ex97_quantum.htm	Edgar Link	pending
ex10-32_001.jpg	Edgar Link	pending
ex23-1_001.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
qubt-20231231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
qubt-20231231_cal.xml	Edgar Link	unprocessable
qubt-20231231_def.xml	Edgar Link	unprocessable
qubt-20231231_lab.xml	Edgar Link	unprocessable
qubt-20231231_pre.xml	Edgar Link	unprocessable
ea0202448-10k_quantum_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$QUBT
Quantum Computing Inc. Stock $qubt

2024 Q1 Form 10-K Financial Statement

#000121390024028799 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QUBT Quantum Computing Inc. Stock $qubt

2024 Q1 Form 10-K Financial Statement

#000121390024028799 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QUBT
Quantum Computing Inc. Stock $qubt